A study of the action of risperidone at 5-HT2A receptors
Risperidone is an ‘atypical’ antipsychotic and is approved by the USFDA mainly for the treatment of schizophrenia and symptoms of bipolar disorder. Risperidone (an SDA or serotonin-dopamine antagonist) has ~20-fold higher affinity at 5-HT2A receptors over dopamine D2 receptors, which makes it more e...
Main Author: | Gaitonde, Supriya A |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2016
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/4112 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=5174&context=etd |
Similar Items
-
“DESIGN AND SYNTHESIS OF MOLECULAR PROBES FOR THE STUDY OF 5-HT2A AND H1 RECEPTORS”
by: shah, Jitesh
Published: (2009) -
α2-ADRENOCEPTOR AND 5-HT3 SEROTONIN RECEPTOR LIGANDS AS POTENTIAL ANALGESIC ADJUVANTS
by: Alley, Genevieve
Published: (2012) -
Exploring the effects of 5-HT2A and AMPA receptors on brain 5-HT via a mechanism-based pharmacodynamic model
by: Zhou, Zhu
Published: (2014) -
5-HT3 Receptor Ligands and Their Effect on Psychomotor Stimulants
by: Worsham, Jessica Nicole
Published: (2008) -
Exploring the effect of alpha2 receptor on brain 5-HT via a mechanism-based pharmacodynamic model
by: Sun, Jingjing
Published: (2012)